nVerses Capital LLC Invests $95,000 in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

nVerses Capital LLC bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 1,400 shares of the company’s stock, valued at approximately $95,000.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Commonwealth Equity Services LLC lifted its stake in Acadia Healthcare by 3.5% in the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock valued at $513,000 after buying an additional 257 shares during the last quarter. Sivik Global Healthcare LLC increased its holdings in shares of Acadia Healthcare by 14.3% in the 2nd quarter. Sivik Global Healthcare LLC now owns 80,003 shares of the company’s stock valued at $5,403,000 after acquiring an additional 10,003 shares during the period. Principal Financial Group Inc. raised its position in Acadia Healthcare by 19.4% in the 2nd quarter. Principal Financial Group Inc. now owns 643,521 shares of the company’s stock valued at $43,463,000 after purchasing an additional 104,359 shares during the last quarter. Innealta Capital LLC acquired a new stake in Acadia Healthcare during the 2nd quarter worth $164,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in Acadia Healthcare by 46.0% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 27,483 shares of the company’s stock worth $1,856,000 after purchasing an additional 8,657 shares during the last quarter.

Analysts Set New Price Targets

ACHC has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft upped their target price on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Royal Bank of Canada reaffirmed an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a research note on Wednesday, May 22nd. Barclays lowered their target price on Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating on the stock in a research note on Thursday, August 1st. StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Tuesday, May 21st. Finally, TD Cowen lowered their price objective on shares of Acadia Healthcare from $101.00 to $91.00 and set a “buy” rating on the stock in a research report on Friday, May 17th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $87.44.

Acadia Healthcare Trading Down 4.5 %

NASDAQ:ACHC opened at $78.21 on Wednesday. The stock has a market capitalization of $7.26 billion, a price-to-earnings ratio of -558.64, a PEG ratio of 2.36 and a beta of 1.32. Acadia Healthcare Company, Inc. has a 1 year low of $62.04 and a 1 year high of $87.77. The stock has a fifty day moving average price of $70.66 and a two-hundred day moving average price of $72.51. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The firm had revenue of $796.00 million during the quarter, compared to analysts’ expectations of $784.38 million. During the same quarter last year, the business earned $0.92 earnings per share. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.51 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.